Lobe Sciences upsizes non-brokered private placement to 25,411,762 shares at $0.085 each

Reuters2026/08/28 23:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Lobe Sciences upsized its non-brokered private placement of common shares priced at $0.09 per share.
First tranche closed Aug. 19, 2026: 24,705,880 shares issued for gross proceeds of $2.1 million.
Second tranche planned: 705,882 shares for about $60,000; total would reach 25,411,762 shares for $2.16 million.
Proceeds earmarked for working capital, corporate purposes, progression of the S-100 sickle cell drug candidate toward human trials.
Shares remain unregistered under the U.S. Securities Act; second tranche still requires Canadian Securities Exchange acceptance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lobe Sciences Ltd. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608281900ACCESSWRNAPR_____1214127) on August 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Lobe Sciences upsizes non-brokered private placement to 25,411,762 shares at $0.085 each

You may also like

Crypto prices